FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

929011000001108: Xyloproct ointment (AstraZeneca) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16899301000001110 Xyloproct ointment (AstraZeneca) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
103456601000001114 Xyloproct 5%/0.275% ointment (Aspen Pharma Trading Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xyloproct ointment (AstraZeneca) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Is a Lidocaine 5% / Hydrocortisone acetate 0.275% ointment true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has active ingredient Hydrocortisone acetate false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has excipient Cetyl alcohol false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Is a Xyloproct true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has specific active ingredient Hydrocortisone acetate true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has specific active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has active ingredient Hydrocortisone true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xyloproct ointment (AstraZeneca) 30 gram Is pack of False Xyloproct ointment (AstraZeneca) Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 20 gram Is pack of False Xyloproct ointment (AstraZeneca) Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 20 gram Has AMP True Xyloproct ointment (AstraZeneca) Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has AMP True Xyloproct ointment (AstraZeneca) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start